Bayer Pharma AG, one of the world's leading global specialty pharmaceutical companies, licensed Genedata Biologics® as the backbone of their Biologics Data Platform (BDP). The BDP supports biologics data management and analysis at Bayer Pharma R&D sites worldwide, where they are developing novel protein-based therapeutics for diseases such as cancer, hemophilia, and multiple sclerosis. The platform provides shared data storage and data exchange to synchronize Bayer Pharma’s activities from biologics screening all the way through to production. Developed for both antibody-based and other protein therapeutics, the platform supports key tasks such as library generation, laboratory logistics, biologics registration, and analytics. It directly interacts with laboratory equipment, including screening robots, and integrates into Bayer Pharma’s existing IT infrastructure.